Discovery of the breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) genes [1,2] led to the development of genetic tests to identify individuals at risk for hereditary breast and ovarian cancer (HBOC). The gene discussed is BRCA1; the disease is breast cancer.